Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical business.
Related Posts
Tesla Reports Higher Profit in Third Quarter
The surprise increase was the first since the electric-car maker’s earnings began to slide earlier this year as it turned to deep price cuts and […]
Empty Tables and Rising Costs Push More Restaurants Into Bankruptcy
Red Lobster, Roti and other chains are closing locations as chapter 11 filings grow.
Insurers Pocketed $50 Billion From Medicare for Diseases No Doctor Treated
Questionable diagnoses of HIV and other maladies triggered extra Medicare Advantage payments. “It’s anatomically impossible,” said one doctor about some cataract diagnoses.